颈动脉硬化粥样狭窄患者的临床治疗方法分析.docVIP

精品论文 参考文献 颈动脉硬化粥样狭窄患者的临床治疗方法分析 张福兰 (山东省菏泽市鄄城县人民医院 274600) 【摘要】目的：探讨临床治疗颈动脉硬化粥样狭窄患者的方法及疗效。方法：对2011~2013年我院收治的58例颈动脉硬化粥样狭窄患者进行随机数字表法分组，每组29例，将其中实施常规西药（辛伐他汀）治疗者设为对照组，将在对照组治疗的条件下施加丹黄通脉胶囊治疗者设为观察组，评估两组病例的临床治疗结局，总结治疗经验。结果：观察组治疗后的斑块面积是（0.13plusmn;0.04）cm2，较之治疗前、对照组更为理想，比较差异明显（P＜0.05）。观察组治疗后的三酰甘油（TG）、总胆固醇（TC）及高、低密度脂蛋白胆固醇（HDL-C和LDL-C）均要较治疗前有显著性改善（P＜0.05），且除TC外，其余3项血脂指标均要较对照组有优越性（P＜0.05）。结论：为颈动脉硬化粥样狭窄患者提供丹黄通脉胶囊进行治疗，有利于缩小患者的斑块面积，改善其血脂水平，临床疗效相对理想、可靠，是今后医院单位提高本病治疗水平的关键，建议临床普及。 【关键词】颈动脉硬化粥样狭窄；临床治疗；疗效 【中图分类号】R453 【文献标识码】A 【文章编号】1672-5085（2014）24-0032-02 Carotid atherosclerosis in clinical treatment of atherosclerotic stenosis analysis 【Abstract】Objective: To investigate the clinical treatment of carotid atherosclerosis atherosclerotic stenosis and efficacy of the method . Methods: 2011 ~ 2013 in our hospital 58 cases of atherosclerotic stenosis of carotid atherosclerosis in patients randomly grouping, 29 cases in each group , which will be implemented conventional medicine ( simvastatin ) treatment as the control group , the in the control group, the treatment of conditions施加丹yellow circulation capsule treatment observation group , two groups of patients to assess the clinical outcome, summed treatment experience . Results: The treatment of plaque area was (0.13 plusmn; 0.04) cm 2, compared to pre- treatment control group, more desirable , more significant differences (P lt;0.05). After treatment, triglyceride (TG), total cholesterol (TC) and high density lipoprotein cholesterol (HDL-C and LDL-C) have to be compared with before treatment there was a significant improvement (P lt;0.05), and In addition to TC , the other three lipid parameters were compared with the control group to have superiority (P lt;0.05). Conclusion: Patients with carotid atherosclerosis atherosclerotic stenosis Dan Wong Tong Mai capsules provide treatment , help reduce the patients plaque area , improve their bloo